Mar 31, 2026 4:12pm EDT NEXGEL Reschedules 2025 Financial Results Conference Call to April 8th at 4:30 P.M. ET to Provide Shareholders with an Update on Its Previously Announced Transaction with Celularity
Mar 25, 2026 9:00am EDT NEXGEL to Report Fourth Quarter and Full Year 2025 Financial Results on March 31st
Mar 12, 2026 8:45am EDT NEXGEL Announces Consideration Terms of Agreement to License and Acquire Portfolio of Commercial-Stage Regenerative Biomaterial Products
Mar 10, 2026 8:45am EDT NEXGEL Signs Definitive Agreement to License and Acquire Transformative Portfolio of Commercial-Stage Regenerative Biomaterial Products
Feb 10, 2026 9:00am EST NEXGEL Announces Financing of $1.797 Million Relating to an Acquisition Targeted to Close in the First Quarter of 2026, Subject to the Completion of Due Diligence
Dec 16, 2025 8:00am EST NexGelRx Receives Additional Investment from Eric Gruntfest of Diesis Holdings, LLC and Appoints Him as Board Observer and Strategic Advisor
